These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2967472

  • 1. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
    Larsen FG, Jakobsen P, Larsen CG, Kragballe K, Nielsen-Kudsk F.
    Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
    [Abstract] [Full Text] [Related]

  • 2. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
    Larsen FG, Jakobsen P, Larsen CG, Nørgaard A, Kragballe K, Nielsen-Kudsk F.
    Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
    [Abstract] [Full Text] [Related]

  • 3. The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients.
    Larsen FG, Jakobsen P, Eriksen H, Grønhøj J, Kragballe K, Nielsen-Kudsk F.
    J Clin Pharmacol; 1991 May; 31(5):477-83. PubMed ID: 1828811
    [Abstract] [Full Text] [Related]

  • 4. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
    Kingston TP, Matt LH, Lowe NJ.
    Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
    [Abstract] [Full Text] [Related]

  • 5. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
    Reiners J, Löfberg B, Kraft JC, Kochhar DM, Nau H.
    Reprod Toxicol; 1988 Jan; 2(1):19-29. PubMed ID: 2980988
    [Abstract] [Full Text] [Related]

  • 6. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR, Geiger JM.
    Acta Derm Venereol Suppl (Stockh); 1989 Jan; 146():206-7. PubMed ID: 2532847
    [Abstract] [Full Text] [Related]

  • 7. Etretin. A replacement for etretinate.
    O'Brien TJ.
    Int J Dermatol; 1990 May; 29(4):270-1. PubMed ID: 2142483
    [No Abstract] [Full Text] [Related]

  • 8. Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients.
    Vahlquist A.
    Dermatologica; 1987 May; 175(5):224-8. PubMed ID: 2960573
    [Abstract] [Full Text] [Related]

  • 9. Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies.
    Geiger JM, Czarnetzki BM.
    Dermatologica; 1988 May; 176(4):182-90. PubMed ID: 2967779
    [Abstract] [Full Text] [Related]

  • 10. Acitretin : A Review of its Pharmacology and Therapeutic Use.
    Pilkington T, Brogden RN.
    Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
    Larsen FG, Nielsen-Kudsk F, Jakobsen P, Kragballe K.
    Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684
    [Abstract] [Full Text] [Related]

  • 12. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
    Löfberg B, Reiners J, Spielmann H, Nau H.
    Dev Pharmacol Ther; 1990 Nov; 15(1):45-51. PubMed ID: 2147001
    [Abstract] [Full Text] [Related]

  • 13. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
    Gollnick H, Bauer R, Brindley C, Orfanos CE, Plewig G, Wokalek H, Hoting E.
    J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
    [Abstract] [Full Text] [Related]

  • 14. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H, Sönnichsen N.
    Acta Derm Venereol Suppl (Stockh); 1989 Sep; 146():176-7. PubMed ID: 2532846
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of psoriasis with etretin: a preliminary report.
    Madhok R, Muller SA, Dicken CH.
    Mayo Clin Proc; 1987 Dec; 62(12):1084-9. PubMed ID: 2960861
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H, Rinck G, Bitterling T, Orfanos CE.
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [Abstract] [Full Text] [Related]

  • 17. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K, Jansén CT, Geiger JM, Bjerke JR, Falk ES, Gip L, Hjorth N, Lauharanta J, Mork NJ, Reunala T.
    Acta Derm Venereol; 1989 Jan; 69(1):35-40. PubMed ID: 2563606
    [Abstract] [Full Text] [Related]

  • 18. Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
    Vahlquist A, Rollman O, Pihl-Lundin I.
    Acta Derm Venereol; 1986 Jan; 66(5):431-4. PubMed ID: 2431582
    [Abstract] [Full Text] [Related]

  • 19. Acitretin. A review of its pharmacology and therapeutic use.
    Pilkington T, Brogden RN.
    Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 1377120
    [Abstract] [Full Text] [Related]

  • 20. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats.
    Chien DS, Sandri RB, Tang-Liu DS.
    Drug Metab Dispos; 1992 Apr; 20(2):211-7. PubMed ID: 1352212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.